Novel antiarrhythmic class III drug nibentan: From experimental studies to clinical practice

被引：0
|
作者：
Rosenshtraukh, LV [1 ]
Ruda, MY [1 ]
Golitsin, SP [1 ]
Maykov, EB [1 ]
机构：
[1] Russian Cardiol Sci Ind Complex, Moscow, Russia
来源：
KARDIOLOGIYA | 2003年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 68
页数：3
相关论文
共 50 条
  • [41] Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol
    Sköld, AC
    Danielsson, BR
    PHARMACOLOGY & TOXICOLOGY, 2001, 88 (01): : 34 - 39
  • [42] CURRENT STATUS OF CLASS-III ANTIARRHYTHMIC DRUG-THERAPY
    RODEN, DM
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (06): : B44 - B49
  • [43] Structural basis of class III antiarrhythmic drug binding to HERG channels
    Kamiya, K
    Mitcheson, J
    Kodama, I
    Sanguinetti, MC
    CIRCULATION, 2001, 104 (17) : 27 - 27
  • [44] Ranolazine on top of antiarrhythmic class-III drug therapy: Safe electrophysiologic profile in an experimental model of proarrhythmia
    Frommeyer, G.
    Kaese, S.
    Kaiser, D.
    Pott, C.
    Eckardt, L.
    Milberg, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1046 - 1046
  • [45] Mechanisms of termination of atrial fibrillation by class I antiarrhythmic drugs: Evidence from clinical, experimental, and mathematical modeling studies
    Nattel, S
    Kneller, J
    Zou, RQ
    Leon, LJ
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (10) : S133 - S139
  • [46] ATRIAL-FLUTTER CAN BE TERMINATED BY A CLASS-III ANTIARRHYTHMIC DRUG BUT NOT BY A CLASS-IC DRUG
    CRIJNS, HJGM
    VANGELDER, IC
    KINGMA, JH
    DUNSELMAN, PHJM
    GOSSELINK, ATM
    LIE, KI
    EUROPEAN HEART JOURNAL, 1994, 15 (10) : 1403 - 1408
  • [47] EXPERIMENTAL AND PRELIMINARY CLINICAL-RESULTS OBTAINED WITH THE NEW CLASS IB-ANTIARRHYTHMIC DRUG BARUCAINIDE
    GULKER, H
    HEUER, H
    FRENKING, B
    HAVERKAMP, W
    HINDRICKS, G
    BOZEK, B
    BREMKES, C
    ASCHE, KD
    WITTHOFT, D
    ZEITSCHRIFT FUR KARDIOLOGIE, 1988, 77 (09): : 587 - 594
  • [48] AL-275 - Novel class III antiarrhythmic drug: Pharmacological properties and special characteristics of mechanism of action
    Kaverina, NV
    Lyskovtsev, VV
    Sokolov, SF
    Kishchuk, EP
    Turilova, AI
    Poppe, KH
    Marx, D
    Klappenstuk, M
    KARDIOLOGIYA, 2000, 40 (07) : 42 - 47
  • [49] INVIVO AND INVITRO METABOLISM STUDIES ON A CLASS-III ANTIARRHYTHMIC AGENT
    VICKERS, S
    DUNCAN, CA
    KARI, PH
    HICHENS, M
    PITZENBERGER, SM
    HOMNICK, CF
    ELLIOTT, JH
    VYAS, KP
    FASEB JOURNAL, 1992, 6 (04): : A1570 - A1570
  • [50] INVIVO AND INVITRO METABOLISM STUDIES ON A CLASS-III ANTIARRHYTHMIC AGENT
    VICKERS, S
    DUNCAN, CA
    KARI, PH
    HOMNICK, CF
    ELLIOTT, JM
    PITZENBERGER, SM
    HICHENS, M
    VYAS, KP
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (03) : 467 - 473
12345